Turning Point Therapeutics, Inc.
DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES
Last updated:
Abstract:
The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
Status:
Application
Type:
Utility
Filling date:
21 Feb 2020
Issue date:
9 Jul 2020